Products and Resources Catalog

National Recovery Month (Recovery Month), which started in 1989, is a national observance held every September to promote and support new evidence-based treatment and recovery practices, the nation’s strong and proud recovery community, and the dedication of service providers and communities who make recovery in all its forms possible. Hosted by the ATTC, and MHTTC Network, in collaboration with SAMHSA, this hour-long event showcases the winners of the 2022 Recovery Innovation Challenge through a “talk-show” format. Hear from four of the ten Challenge Winners who share their innovative strategies for recovery, lessons learned from implementation, and recommendations for replication in other communities. Download the slides by clicking on the green "download" button above.

This FREE Virtual Learning Series is designed enhance education and training related to substance use disorders and to gain comprehensive knowledge and valuable insights into the world of addiction, focusing on four significant substances: alcohol, tobacco, opioids, and stimulants. This engaging and informative series has been designed to equip individuals, families, educators, and healthcare professionals with the tools they need to understand, prevent, and address substance abuse issues effectively. Whether you're seeking personal knowledge, professional development, or the tools to help someone in need, our Substance Abuse Virtual Learning Series offers a valuable opportunity to make informed choices and contribute to healthier, substance-free lives. Together, we can break the chains of addiction and create a brighter, healthier future for all. Join us in this transformative journey towards recovery and prevention. Module 1: Alcohol Use Disorder Screening and Treatment This module introduces Alcohol Use Disorder Screening and Treatment in the Latino population. Module 2: Tobacco Use Disorder Screening and Treatment This module introduces the Treatment of Tobacco Use Disorder in Latino Populations. Module 3: Opioid Use Disorder Screening and Treatment This module introduces the Screening and Treatment of Opioid Use Disorder in Latino Populations. Module 4: Stimulant Use Disorder Screening and Treatment This module introduces Screening and Treatment of Stimulant Use Disorder in Latino Populations.   Español Series de aprendizaje sobre el trastorno por consumo de sustancias Esta serie de aprendizaje virtual GRATIS está diseñada para mejorar la educación y la formación relacionadas con los trastornos por consumo de sustancias y para obtener conocimientos integrales y valiosos sobre el mundo de la adicción, centrándose en cuatro sustancias importantes: alcohol, tabaco, opioides y estimulantes. Esta serie atractiva e informativa ha sido diseñada para equipar a individuos, familias, educadores y profesionales de la salud con las herramientas que necesitan para entender, prevenir y abordar los problemas de abuso de sustancias de manera efectiva. Ya sea que esté buscando conocimiento personal, desarrollo profesional o las herramientas para ayudar a alguien necesitado, nuestra serie de aprendizaje virtual sobre abuso de sustancias ofrece una valiosa oportunidad para tomar decisiones informadas y contribuir a una vida más saludable y libre de sustancias. Juntos, podemos romper las cadenas de la adicción y crear un futuro más brillante y saludable para todos. Únase a nosotros en este viaje transformador hacia la recuperación y la prevención. Módulo 1: Detección y Tratamiento del Trastorno por Consumo de Alcohol . Este módulo presenta Detección y Tratamiento del Trastorno por consumo de Alcohol y Sustancias en la población Latina. Módulo 2: Detección y Tratamiento del Trastorno por el Uso del Tabaco Este módulo presenta el Tratamiento del Trastorno por Consumo de Tabaco en Poblaciones Latinas. Módulo 3: Detección y Tratamiento del Trastorno por el uso de opioides Este módulo presenta los Exámenes de detección y tratamiento del trastorno por consumo de opioides en poblaciones Latinas. Módulo 4: Detección y Tratamiento del Trastorno por el uso de Estimulantes Este módulo presenta Detección y tratamiento del trastorno por consumo de estimulantes en poblaciones Latinas.    

This series will provide a review of common crisis situations, overview of crisis intervention guidelines and strategies, and describe clinical responses to common behavioral health emergencies and crises in clinical practice. Session 4: Reflections Upon Important Crisis Intervention Topics - Q&A (September 26, 2023) Our speakers are Dr. Ken Winters, Dr. Jacque Gray, Nelda Huskie, and Dr. Kathy Tomlin. Join us to gain skills in handling crisis events.

Join us for ESAS: Adolescent Brain Maturation and Health: Intersections on the Developmental Highway. This event took place on September 6, 2023.

This series will provide a review of common crisis situations, overview of crisis intervention guidelines and strategies, and describe clinical responses to common behavioral health emergencies and crises in clinical practice. Session 3: Case-Illustrations (September 19, 2023) Our speakers are Dr. Ken Winters, Dr. Jacque Gray, Nelda Huskie, and Dr. Kathy Tomlin. Join us to gain skills in handling crisis events. Click HERE to access the event recording. 

This series will provide a review of common crisis situations, overview of crisis intervention guidelines and strategies, and describe clinical responses to common behavioral health emergencies and crises in clinical practice. Session 1: Overview of Addressing Behavioral Crises (August 29, 2023) Our speakers are Dr. Ken Winters, Dr. Jacque Gray, Nelda Huskie, and Dr. Kathy Tomlin. Join us to gain skills in handling crisis events. Click HERE to access the event recording. 

This presentation titled, "Addiction Technology Transfer: Bridging the Gap Between Science and Service for 30 Years" provides participants with an overview of the New England ATTC and key accomplishments over the past three decades.

This presentation titled, “Eliminating Disparities, Building Equity, and the Enhanced CLAS Standards: Current Context and Approaches” reviews current approaches to ensure adherence to CLAS standards and eradicate health disparities.

Beyond sobriety, programs dealing with substance use disorders have embraced a more comprehensive goal: Recovery. There are four recognized domains of recovery: Health, Home, Purpose, and Community. There are a myriad of resources, both internal and external, that make up recovery capital. As a person begins their journey, they draw on their initial store of recovery capital and as that journey continues, they gain more recovery capital. More recovery capital, more recovery. More recovery, more recovery capital. By assisting an individual identify their recovery capital and make plans for its increase, their recovery becomes stronger.  This session, presented by Norma Jaeger, PhD (ABD), Executive Director of Recovery Idaho, explored the many potential elements of recovery capital and how to support an individual in building more recovery capital to support their life in recovery. View recording | Download slides | Download handouts: Recovery Capital Scale, Recovery Capital Worksheets 

The New England ATTC co-hosted the Recovery Science and Harm Reduction (RSHR) Reading Group meeting on September 21, 2023. This discussion reviewed the article, “Understanding Stigma Through the Lived Experiences of People With Opioid Use Disorder.” Article link: https://pubmed.ncbi.nlm.nih.gov/37390780/ View the September 2023 RSHR Reading group meeting summary that includes a brief article summary and key themes that arose in discussion with the participants.

Each person who enters recovery is as unique as their story. And this month, in honor of recovery month, we are bringing you recovery stories from people in diverse populations. Hear what people in these communities want providers to know. Episode 4: Jazie is a non-binary person who is coming up on their 2nd sober anniversary. Jazie recognizes the older version of themselves taught them many things and acknowledges that they would not be the best version of themselves without that former self.    

Each person who enters recovery is as unique as their story. And this month, in honor of recovery month, we are bringing you recovery stories from people in diverse populations. Hear what people in these communities want providers to know. Episode 3: Casey explains that recovery does not have to be abstinence only.  She discusses her thoughts on why she practices abstinence only now, but she may not always. She discusses why she may use substances in spiritual practices or rituals that her culture has used for centuries, and that does not contradict being in recovery. Casey uses her voice to stand up for who she stands on.     

    Throughout the United States, an estimated 1-2 million older adults are in need of treatment for substance use disorders (SUDs). This presentation addresses evidence-based best practices for treating older adults with substance use disorder.     LEARNING OBJECTIVES: Identify commonly used drugs for older adults and the risks associated with these substances. Describe logistical differences in treating and responding to older adults with SUD. Present effective treatment strategies for treating older adults.     TRAINER: Randall Webber, MPH, CADC, has worked in the addiction field for the past 45+ years as a counselor, program director and trainer. He has provided training on street drug pharmacology, addiction science, counselor ethics, and substance abuse treatment strategies. Randall has authored or co-authored numerous publications and has held teaching positions at several colleges and universities. He also serves on the board of directors of the Illinois Association of Addiction Professionals     The Great Lakes A/MH/PTTC is offering this training for individuals working in HHS Region 5: IL, IN, MI, MN, OH, WI. This training is being provided in response to a need identified by Region 5 stakeholders.

Recovery Month flyer

This module aims to educate about harm reduction as an evidence-based public health approach to minimizing adverse health consequences and other events that may be experienced by people who use psychoactive substances.  Harm reduction strategies and how to put them into practice in the process of helping to achieve behavior change are discussed.

Este módulo tiene como objetivo educar al lector sobre la reducción de daños como un enfoque de salud pública, basado en evidencia, para minimizar las consecuencias adversas a la salud y otras áreas de la vida que pueden experimentar las personas que consumen sustancias psicoactivas.  Se discuten estrategias de la reducción de daños y cómo ponerlas en práctica en el proceso de ayuda para lograr cambios de conducta.

This series will provide a review of common crisis situations, overview of crisis intervention guidelines and strategies, and describe clinical responses to common behavioral health emergencies and crises in clinical practice. Session 2: Select Clinical Topics when Helping Clients Deal with a Crisis (September 12, 2023) Our speakers are Dr. Ken Winters, Dr. Jacque Gray, Nelda Huskie, and Dr. Kathy Tomlin. Join us to gain skills in handling crisis events. Click HERE to access the event recording.

On September 1, 2023, from 1-3pm CT, the National AI/AN ATTC will feature a third installment of its virtual Native storytelling series. This broadcast will include multiple AI/AN Storytellers sharing teachings, lessons, and oral knowledge passed down for thousands of years. Portions of this event may not be recorded to honor the culturally sensitive nature of these traditional stories and lessons.

    The ATTC Network hosted a webinar by Abt Associates as part of a recent SAMHSA Advisory.   Summary: The last decade has seen immense changes in digital health, with increased use of electronic medical records, mobile applications, and wearable devices. During the COVID-19 pandemic, telehealth expanded access to care for millions of people and was a critical resource to meet the behavioral healthcare needs of individuals with mental health conditions and substance use disorders. Digital therapeutics (DTx) are health software intended to treat or alleviate a disease, disorder, condition, or injury by generating and delivering a medical intervention that has a demonstrable positive therapeutic impact on a patient's health. DTx play an important role in facilitating care through technology. This webinar will introduce the audience to a recently released SAMHSA advisory on DTx and the benefits of their use in behavioral health. The webinar will describe research, regulatory, and reimbursement implications for DTx, selection and implementation considerations, and issues related to equitable access of DTx in behavioral health. Through a roundtable format, the webinar will also highlight one state’s success in integrating DTx into its service provision.   Watch Now: DTx Webinar SAMHSA Guide: DTx Advisory Slide Deck: DTx Presentation

This is a recording of the webinar presented 9-13-23 by JK Costello

    The Roadmap for Training and Technical Assistance Efforts in Substance Use Service Administration monograph (2019) was meant to serve as a guide for instituting and practically applying the Culturally and Linguistically Appropriate Services (CLAS) Standards across the areas of prevention, substance use disorder, and behavioral health. Join our long-time trainer and subject matter expert, Harold Gates, MSSW, CISW, HS-BCP, as we revisit these efforts and learn how to move DEI beyond good intentions to make a difference in the lives of an ever-growing and diverse client population. In order to do this, we should approach the topic with the “fierce urgency of now,” to quote Dr. Martin Luther King. This webinar will start us off on a journey to do just that! We will be using Lily Zheng's DEI Deconstructed: Your No-Nonsense Guide to Doing the Work and Doing It Right as a reference resource throughout this training.  “Instead of like a zero-sum game we all need to engage in DEI for collective learning, for collective growth. We are doing this work to get a greater understanding of how different populations experience the workplace. And to the extent that some populations are not being treated well, we're going to understand why and rectify those inequities because we really care about a workplace that's fair. That framing tends to really activate people.” Lily Zheng-DEI Deconstructed     LEARNING OBJECTIVES: Describe the Culturally and Linguistically Appropriate Services (CLAS) Standards. Describe one way the CLAS Standards can help you with your DEI initiatives. Share what are you trying to achieve through your DEI work Learn if your organization has done a CLAS or DEI assessment and used data to measure your success or opportunities for continuous improvement Describe stakeholder involvement in your DEI efforts. Understand what would the work look like when it’s done effectively     Save these Dates for the DEI Learning Collaborative where will dig deeper into Lily Zheng's DEI Deconstructed: Your No-Nonsense Guide to Doing the Work and Doing It Right  An application will be available after the September webinar. Tuesday October 3 at 12-1pm Central Tuesday November 7 at 12-1pm Central Tuesday December 5 at 12-1pm Central Tuesday January 9 at 12-1pm Central     TRAINER: Harold Gates, MSSW, CISW, HS-BCP, President, Midwest Center for Cultural Competence, LLC Harold Gates is the president and co-founder of the Midwest Center for Cultural Competence, LLC, which was established in 2003. The Center provides training, education, and consultation for organizations that are seeking to provide culturally and linguistically appropriate services, with the goal of helping to create a culturally competent multicultural community.

  Treatment for Individuals who Use Stimulants TRUST A Protocol Using Empirically-Supported Behavioral Treatments for People with Stimulant Use Disorders     Purpose of the TRUST-MAIN Manual The authors of this manual have been involved in StimUD-related research, treatment, and training efforts for over 30 years. Over this period, the research on StimUD and its treatment has vastly increased and there is a great interest in better understanding StimUD and providing effective treatment for people who use cocaine and methamphetamine. We have produced this manual to promote the use of research-supported strategies for StimUD treatment. The manual attempts to combine a number of strategies into a framework that is appropriate for use by clinicians in settings where people with StimUD receive treatment. This manual is not intended to be a cookbook and the materials used and the framework for their use are not intended to be an inflexible, one-size-fits-all prescription. At the end of the manual, we list a variety of treatment materials (see Appendix) that can be added or substituted for the ones we are recommending. We provide the contents of this manual and the framework for combining these treatment materials as one example for how research-supported strategies can be combined into a structured treatment experience. The manual was developed at a time when CM with adequate incentives was considered impossible in the U.S. Hence, this manual was produced to offer a possible, albeit a non-evidence-based and certainly less effective alternative to CM. As evidence-based CM protocols using adequate incentives are increasingly being developed and implemented in the U.S., there is interest in having CM delivered within a framework of other evidence-based behavioral support. The use of the materials in the TRUST Manual to augment CM treatment is another possible use of the manual, either in the form of a 12-week framework, or as ad hoc behavioral support materials. The audience for the manual includes healthcare professionals who provide treatment services for individuals with StimUD. One category of these professionals who we particularly hope will benefit are therapists and other behavioral health clinicians who work in substance use disorder specialty care treatment programs. The manual has been written with this group in mind.   The manual intends to: Provide new information about the use and effects of cocaine and methamphetamine. Present several key clinical challenges that clinicians face when treating this population. Review the evidence-based treatment strategies for StimUD treatment. Discuss how motivational interviewing (MI) is central to the effective engagement of individuals in treatment and to assisting them with behavior change during treatment. Present how elements of community reinforcement approach (CRA) and cognitive behavioral therapy (CBT) can be used to assist individuals with StimUD to reduce/discontinue their drug use and prevent relapse. Describe a procedure for incorporating positive incentives into the treatment milieu and/or support the use of CM for the treatment of StimUD. Provide information and guidance for how physical exercise can benefit individuals who are attempting to reduce/discontinue their use of methamphetamine and cocaine. Describe a plan for providing continuing care to assist individuals to sustain the progress they have made in a structured treatment program. List an array of manuals and training resources for other research-supported substance use disorder treatment approaches.   For those working with people receiving care for Opioid Use Disorder, an adapted version is available Treatment for Individuals who Use Stimulants while on MOUD TRUST—MOUD THERAPIST MANUAL & PATIENT WORKBOOK       Purpose of the TRUST-MOUD Manual The TRUST MOUD Manual is intended to be used with patients who are struggling with stimulant (cocaine/amphetamine) use while in treatment for OUD with methadone, buprenorphine, or naltrexone. Working with patients presenting in MOUD treatment is a challenging, yet incredibly rewarding experience. While it is rewarding, it can also be frustrating. Stimulant use among these patients is common and many patients don’t see their use as problematic. In fact, for some patients who use stimulants sporadically, they may not need treatment. But certainly, for some patients on MOUD, cocaine/meth use is extremely detrimental to the effectiveness of their MOUD treatment and is a serious health problem. However, in many cases, regardless of the severity of use, the patients often don’t recognize their stimulant use as a problem, and they are not interested in intensive treatment. The materials in the TRUST MOUD Manual attempt to provide this patient population with a useful set of information in a format that they find acceptable. The materials adopt CRA, CBT, and MI content and present it in a clear and relevant form that addresses the challenges they face while in MOUD treatment. We try to avoid long, didactic, lecturing materials, but rather try to create accessible topics and examples. TRUST was developed with flexibility in mind to optimize patient engagement and retention. TRUST materials can be presented in 1:1 sessions and can be scheduled with patients or in on-going stimulant treatment groups. Topics can be presented in a sequence and frequency that lets therapists select content to meet patient needs. The 24 TRUST worksheets can be used in a flexible manner to be relevant and useful to patients. Consistency is important when using the TRUST Manual. Set and adhere to meeting days and times. Start and end sessions on time. If used in a group format, have some group participation guidelines. Adhering to a specific session format and timing will enhance patients’ understanding of the group/individual session process and will allow them to focus on acquisition of new material. Patients using stimulants will undoubtedly experience cognitive impairment as they participate in sessions and utilize the TRUST materials. Slowing down to allow patients to gather their thoughts and express themselves during group or individual sessions is important. In addition, using multi-media and repetition can be helpful for patients to grasp new concepts. Use of Motivational Interviewing as a fundamental style and interpersonal approach is essential to success when using TRUST materials. Ideally, TRUST session attendance should be paired with medication visit attendance to reduce the travel burden on patients. This is especially true in rural areas, where public transportation is non-existent, or when a patient has employment, education, or homemaking responsibilities. When possible, patients should have an opportunity to determine therapy visit days and times based upon their scheduling needs. Research has shown that aerobic exercise improves cognitive capacity, reduces depression and anxiety, and improves cardiac and pulmonary function for individuals with stimulant use disorder. Several of the TRUST worksheets discuss the benefits of exercise as part of a treatment effort to reducing stimulant use. Encouraging patients to exercise will also help them to manage emotional highs and lows and help them structure their day. Getting patients to exercise is often difficult and requires ongoing encouragement and support. The TRUST materials and their use with patients on MOUD should be used with a strong harm reduction foundation. The #1 priority for this group of patients is retention in treatment with MOUD. Participation in treatment activities with TRUST materials, when appropriate, should be encouraged, rewarded, and praised. In our opinion, requiring treatment attendance with TRUST materials, with a threat of MOUD discontinuation is never justified. In an era of lethal drugs including fentanyl, retention on MOUD is essential. Other harm reduction activities should be combined with TRUST materials. Access to safe injection supplies, ready access to naloxone and fentanyl test strips, and as new drugs emerge (e.g., xylazine), it is critical to provide new information and test strips as they become available. Many patients in MOUD treatment have multiple life challenges, including use of numerous drugs and alcohol, food insecurity, being unhoused, unemployment, as well as both mental health and physical health issues. To be successful, patients will need to be retained in treatment for a significant period of time, if not for a lifetime. These issues are not going to be resolved overnight, but rather through consistent and prolonged effort. We hope these materials can be useful to your work with patients on MOUD.   Authors Richard Rawson, PhD Richard A. Rawson, PhD, is Professor Emeritus at the UCLA Department of Psychiatry and a Research Professor at the Vermont Center for Behavior and Health at the University of Vermont. He received a Ph.D. in experimental psychology from the University of Vermont in 1974. Dr. Rawson conducted numerous clinical trials on pharmacological and psychosocial addiction treatment and extensive system evaluation activities in a number of states and countries. He has led addiction research and training projects for the United Nations, the World Health Organization, and the U.S. State Department, exporting science-based knowledge to many parts of the world. Dr. Rawson has published 3 books, 40 book chapters, and over 250 peer-reviewed articles and has, for almost 50 years, conducted workshops, paper presentations, and training sessions in many areas of the world.   Albert Hasson, MSW Albert L. Hasson received his MSW from UCLA and has worked in the field of addiction medicine as a researcher and a treatment provider since 1977. Mr. Hasson participated in the development of the evidence-based Matrix Model, a cognitive behavioral intervention for StimUD Treatment, and established the Matrix Institute on Addictions, Los Angeles opioid treatment program. Along with his administrative and clinical experience, Mr. Hasson has extensive experience in implementing and evaluating behavioral and pharmacologic interventions. He has served as a project director and trainer for the Pacific Southwest Addiction Technology Transfer Center at the UCLA Integrated Substance Abuse Programs.   Janice Stimson, PsyD Janice Stimson, PsyD, has worked in the field of addiction treatment since 1998. For 20 years she has worked at the Matrix Institute on Addictions in the role of Clinic Director, overseeing and managing the clinic, seeing clients and supervising staff. At the clinic private adolescent and adult treatment programs coexisted along-side national research studies. Dr. Stimson held key positions in those studies and was responsible for ensuring the success of fulfilling recruitment, training, supervision, and protocol requirements.   Michael McCann, MA Michael McCann, M.A., is one of the founders of the Matrix Institute on Addictions and creators of the Matrix Model. He has overseen the operation of Matrix clinics as well as the integration of many research projects within these sites. He has over 40 years of experience in substance use disorder treatment and research, and has authored or co-authored over 40 articles, books, and manuals. He has trained and lectured extensively on evidence-based behavioral interventions, pharmacologic treatments, methamphetamine dependence, opioid dependence, and on the implementation of evidence-based treatments into clinical practice   Acknowledgements The authors would like to acknowledge the assistance provided by Thomas E. Freese, PhD, Beth Rutkowski, MPH, Gloria Miele, PhD, and Valerie P Antonini, MPH. Christine Morgan provided invaluable support with the production of the manual, along with editing support from Victoria T. Norith and Benjamin Nguyen, MSW, CPH. The materials in this manual include content and worksheets from the Matrix Model Therapist Manual (SAMHSA, 2006); from the Community Reinforcement Approach, plus Vouchers Manual (NIDA, 2020).

This unique 4-part series, presented by the National AI/AN ATTC, provides the viewers with an opportunity to discuss strength-based cultural practices and Summertime AI/AN teachings to our peers, friends, and relatives.

This unique 4-part series, presented by the National AI/AN ATTC, provides the viewers with an opportunity to discuss strength-based cultural practices and Summertime AI/AN teachings to our peers, friends, and relatives. Session sub-topics TBA. This event took place on August 4, 2023.